Stage, grade and pathological characteristics of bladder cancer in the UK : B ritish Association of Urological Surgeons ( BAUS ) Urological Tumour Registry
Authors:
- Gregory B. BousteadGBGregory B. Boustead
- Baus Section Of OncologyBOBaus Section Of Oncology
- 22 January 2014
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 113 (6) , 924-930
Abstract
Objective: To investigate T umour‐ N ode‐ M etastasis ( TNM ) stage and demographics at presentation in a very large, contemporary UK cohort of patients with bladder cancer and compare them with other published series, as little published data exists on the pathological characteristics of bladder cancer at presentation. Patients and Methods: The B ritish Association of Urological Surgeons ( BAUS ) Section of Oncology started a new urological tumour registry in 1998. We performed a data analysis of all bladder cancer cases between 1999 and 2008. Tumour TNM stage, grade and histopathological diagnosis were reviewed along with standard epidemiological data. Results: In all, 69 712 bladder cancer registrations were recorded. Complete T , N and M stage and grade was available for 32 240 patients. The male to female ratio of the study population was 3:1 and the overall median ( sd , range) age at presentation was 73 (11.6, 6–108) years. Final pathological T staging showed that non‐muscle‐invasive bladder cancer accounted for 75% of cases with the remaining 25% being muscle‐invasive disease. Of these patients, 8% had nodal disease and 4% other metastatic sites at presentation. The tumour grade was G 1–2 in 65% and G 3 in 35% of cases. Transitional cell carcinoma ( TCC ) accounted for 92%, squamous cell carcinoma and adenocarcinomas 1.5% each, with 5% other histological variants. Conclusions: Non‐muscle‐invasive TCC accounted for 75% of bladder cancer cases in the UK . The 1973 W orld H ealth O rganization classification remains in widespread use amongst pathologists in the UK . Obtaining complete and standardised staging and pathology reporting systems in bladder cancer remains a challenge.Keywords
This publication has 17 references indexed in Scilit:
- Challenges in the Pathology of Non–Muscle-invasive Bladder Cancer: A Dialogue Between the Urologic Surgeon and the PathologistUrology, 2013
- Completeness of bladder cancer staging in the Danish Cancer Registry, 2004–2009Clinical Epidemiology, 2012
- Occupational cancer in BritainBritish Journal of Cancer, 2012
- Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation ClassificationsEuropean Urology, 2010
- Prognostic Significance of the 2004 WHO/ISUP Classification for Prediction of Recurrence, Progression, and Cancer-Specific Mortality of Non–Muscle-Invasive Urothelial Tumors of the Urinary BladderAmerican Journal of Clinical Pathology, 2010
- Grade and Stage at Presentation Do Not Predict Mortality in Patients With Bladder Cancer Who Survive Their DiseaseJournal of Clinical Oncology, 2009
- Can we still afford bladder cancer?Current Opinion in Urology, 2008
- Bladder Cancer: A Major Public Health IssueEuropean Urology Supplements, 2008
- Bladder cancer: Epidemiology, staging and grading, and diagnosisUrology, 2005
- Clinical versus pathologic staging and the classification of bladder cancerUrology, 1984